Michael A Metzger's Net Worth

Michael A Metzger's net worth is estimated to be at least $8,338,508.23 as of 05/30/2024. CoreStreet's estimation of Michael A Metzger's net worth is based on their sale of stock and current holding of stock.

Michael A Metzger is CEO at Syndax Pharmaceuticals Inc. They have executed at least 15 trades of stock as per SEC Form 4 filings. Their most recent trade was for 5,959 units of SNDX stock on 02/06/2023. Their biggest sale was on 11/04/2020 when they sold 100,000 units of Syndax Pharmaceuticals Inc stock for $2,031,000.00. They typically trade 3 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $8,338,508.23
Most recent insider trade:
  • Feb. 6, 2023

Michael A Metzger's Insider Trading History

Syndax Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Feb. 6, 2023
CEO5,959$27.64Sell$164,706.76
Oct. 6, 2022
CEO16,231$25.29Sell$410,481.99
Oct. 4, 2022
CEO1,280$25.02Sell$32,025.60
Sept. 30, 2022
CEO29,606$25.02Sell$740,742.12
July 25, 2022
CEO31,602$21.06Sell$665,538.12
July 7, 2022
CEO100$21.00Sell$2,100.00
Dec. 20, 2021
COO61,000$20.29Sell$1,237,690.00
Dec. 17, 2021
COO1,676$19.02Sell$31,877.52
Dec. 13, 2021
COO36,609$19.05Sell$697,401.45
Oct. 25, 2021
COO44,704$19.13Sell$855,187.52
Sept. 27, 2021
COO24,437$19.51Sell$476,765.87
Sept. 21, 2021
COO4,808$19.16Sell$92,121.28
Dec. 1, 2020
COO15,000$22.97Sell$344,550.00
Nov. 4, 2020
COO100,000$20.31Sell$2,031,000.00
CTi Biopharma CorpTitleAmountPriceTypeTotal Value
July 5, 2022
Director91,500$6.08Sell$556,320.00